G protein-coupled receptor

5-HT1A receptor

5-hydroxytryptamine receptor 1A

The 5-HT1A receptor is one of the receptors for serotonin. Its gene was identified when the genomic clone G-21, found because it resembles the β-adrenergic receptor, turned out to encode it. The protein is a G protein-coupled receptor with seven transmembrane helices. It couples to the inhibitory G proteins Gi and Go, inhibits adenylyl cyclase and so lowers the level of cyclic AMP.1,2

The receptor does not work in the same way in every cell. Through the βγ subunits of its G proteins it opens G protein-gated inward rectifying potassium channels, which hyperpolarises the membrane, and in the raphe and its target regions it closes N-type voltage-dependent calcium channels, which lowers excitability. Both effects reduce the activity of the neuron. In serotonin neurons the receptor couples mainly to Gi3 and in hippocampal neurons mainly to Gi2. In developing and adult hippocampal neurons it activates the ERK1/2 kinase pathway, while in serotonin neurons it appears to inhibit it.2

The receptor is one of the most abundant serotonin receptors in the brain and occurs in two populations. Autoreceptors sit on the dendrites and cell bodies of serotonin neurons in the raphe nuclei, heteroreceptors on the neurons that receive the serotonin. In the rat brain the mRNA for the receptor is most abundant in the dorsal raphe nucleus, the septum, the hippocampus, the entorhinal cortex and the interpeduncular nucleus. Signals were also found in the olfactory bulb, the cerebral cortex, some thalamic and hypothalamic nuclei, several brainstem nuclei including all the other raphe nuclei, and the dorsal horn of the spinal cord. The distribution of the mRNA generally matches that of the binding sites, which suggests that the receptors sit mostly on the cell bodies and dendrites of the neurons that make them. In the forebrain the heteroreceptor is found on excitatory pyramidal neurons and on inhibitory interneurons.2,3

In post-mortem human brain, autoradiography with the antagonist WAY-100635 showed very dense binding in the hippocampus, the raphe nuclei and the neocortex. Binding in the neocortex was slightly lower than in the hippocampus and lay mainly in the superficial layers, with a faintly labelled band in the deeper layers. The amygdala, septum and claustrum showed low densities. Binding was very low in the basal ganglia (caudate nucleus and putamen), in the cerebellum and in the brainstem outside the raphe nuclei. Serotonin, buspirone, pindolol and 8-OH-DPAT displaced the radioligand. The carbon-11 form of the same compound is used for positron emission tomography (PET), and on human brain sections it gave a similar picture with lower resolution.4

On the serotonin neurons of the dorsal raphe in rats, the 5-HT1A agonists ipsapirone and LY 165163 suppressed firing, while two 5-HT1B compounds had only weak or irregular effects. This made 5-HT1A the most likely candidate for the autoreceptor on the cell bodies and dendrites of these neurons. The autoreceptors work as a brake on the serotonin system: serotonin released in the raphe activates them, and they inhibit the firing of the serotonin neurons. In midbrain slices of mice, 8-OH-DPAT reduced the electrically evoked release of serotonin and the antagonist WAY 100635 blocked this effect, while in slices of mice lacking the receptor 8-OH-DPAT had no effect.5,2,6

Several groups have made mice that lack the receptor. The animals grow normally, are viable and look healthy, and their brains show no obvious structural abnormality. Their tissue levels of serotonin and its metabolite 5-HIAA are normal, and so is the electrically evoked release of serotonin in midbrain slices. In hippocampal slices the 5-HT1B agonist CP93129 inhibited release more strongly in the knockouts than in wild-type mice, which suggests that the 5-HT1B autoreceptors on the nerve terminals might take over part of the work. Mice with one working copy of the gene have about half of the normal receptor density and in most behavioural tests lie between the two extremes.7,6,8

In tests of anxiety the knockout mice behave more fearfully. In an open field they explored the centre less and stayed close to the walls, in an elevated maze they spent less time in the open quadrants, and a novel object made them hesitate longer before approaching. In the elevated plus maze of a second group they entered the open arms less often and spent less time there. Home-cage activity was normal in that study, and in the study of Heisler the mutants moved as much as wild-type mice in the open field, so the effects are not a simple loss of movement. In the open field of the second group the knockouts did explore less overall, and only males showed the shift away from the centre, which the authors think may reflect a floor effect because the females were already very anxious. The effect was weaker in females in the other study. The antagonist WAY100635 lowered the time that wild-type mice spent in the centre of the open field, much as the knockout does, and had no effect in knockout mice. This suggests that the behaviour comes from the missing receptor itself and not from a developmental adaptation. The study of Parks reports the same tendency to avoid a novel and fearful environment.7,6,8

The mutants also behave like treated animals in tests used to screen antidepressants, which reduce immobility in these tests. In the tail suspension test the mutants of Heisler were immobile 85 percent less than wild-type mice. In the forced swim test of Ramboz, wild-type mice became more and more immobile during the session while the knockouts kept up the same level of activity. Ramboz suggested that the missing presynaptic receptors may act like the receptors that desensitise during long antidepressant treatment, and Heisler proposed a disinhibition of the serotonin neurons.7,6

Two compounds are the standard probes of the receptor, the agonist 8-OH-DPAT and the antagonist WAY 100635. 8-OH-DPAT is selective for the receptor, although it also activates the 5-HT7 receptor with ten times lower affinity. In rodents it causes hyperphagia, hypothermia and an anxiolytic response, and WAY 100635 blocks these effects. Mice without the receptor no longer respond to 8-OH-DPAT with a drop in body temperature.2,7

Buspirone, a partial agonist at the receptor, is approved as an anxiolytic. In the raphe nuclei it acts as a full agonist at the presynaptic receptors and inhibits the firing of serotonin neurons. It also blocks dopamine D2 autoreceptors, with an affinity about 15 times weaker than for the 5-HT1A receptor. In generalised anxiety disorder it has been reported to be as effective as diazepam, clorazepate, alprazolam and lorazepam. Unlike the benzodiazepines it is not linked to sedation, physical dependence, or cognitive and psychomotor impairment. Its side effects include dizziness, headaches, nausea, nervousness and paraesthesia.9,2

The ligands of the receptor do not tell the autoreceptors and heteroreceptors apart, so they can have opposing effects. In clinical studies both partial agonists and antagonists of the receptor have been reported to strengthen the effect of antidepressants. With long antidepressant treatment serotonin stays elevated, and the autoreceptor appears to desensitise more strongly than the heteroreceptor, which takes the brake off the serotonin neurons. Ligands that favour one population or one signalling pathway have recently been developed.2

Sources (9)
  1. Fargin et al. 1988Fargin A, Raymond JR, Lohse MJ, et al. (1988) The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor Nature
  2. Albert et al. 2019Albert PR, Vahid-Ansari F (2019) The 5-HT1A receptor: Signaling to behavior Biochimie
  3. Pompeiano et al. 1992Pompeiano M, Palacios JM, Mengod G (1992) Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding J Neurosci
  4. Hall et al. 1997Hall H, Lundkvist C, Halldin C, et al. (1997) Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635 Brain Res
  5. Sprouse et al. 1987Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists Synapse
  6. Ramboz et al. 1998Ramboz S, Oosting R, Amara DA, et al. (1998) Serotonin receptor 1A knockout: an animal model of anxiety-related disorder Proc Natl Acad Sci U S A
  7. Heisler et al. 1998Heisler LK, Chu HM, Brennan TJ, et al. (1998) Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice Proc Natl Acad Sci U S A
  8. Parks et al. 1998Parks CL, Robinson PS, Sibille E, et al. (1998) Increased anxiety of mice lacking the serotonin1A receptor Proc Natl Acad Sci U S A
  9. Loane et al. 2012Loane C, Politis M (2012) Buspirone: what is it all about? Brain Res

Binding affinity (Kᵢ)

31 substances, 45 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.

Human

29 measurements
  • LSDAgonistother reports differ1.3 nMEshleman et al. 2013 · 6 reports
    Assay
    cells expressing human 5-HT1A, [3H]8-OH-DPAT displacement
    Shown value from
    Eshleman et al. 2013, Table 5
    Range
    1.2–9.5 nM in 6 reports
    Error
    ± 0.32 SEM, n = 10

    This is the best-supported value. Other reports differ. 8 reports in all, 1.2–9.5 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Halberstadt et al. 20209.5 nMTable 1
    Jain et al. 20255.9 nMTable S4
    Eshleman et al. 20181.2 nMTable 1
    Janowsky et al. 20142.8 nMTable 1
    Eshleman et al. 20142.5 nMTable 2
    Eshleman et al. 20131.3 nMTable 5
  • 5-MeO-DMTAgonistdepends on assay3.0 nMHalberstadt et al. 2012 · 4 reports
    Assay
    cloned human receptor; [3H]8-OH-DPAT competition binding (NIMH PDSP)
    Shown value from
    Halberstadt et al. 2012, Table 1
    Range
    2.6–10 nM in 4 reports
    Error
    ± 0.20 SEM

    Values depend on the assay, species or conditions, and each is valid only for its own. 5 reports in all, 1.9–10 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Halberstadt et al. 20123.0 nMTable 1
    Puigseslloses et al. 20242.6 nMTable 1
    Jain et al. 202510 nMTable S4
    Glatfelter et al. 20249.5 nMSupplement Figure S1
  • ETH-LAD3.5 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • AL-LAD6.0 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • BufoteninAgonist8.3 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • 5-MeO-MiPTAgonistother reports differ25 nMPuigseslloses et al. 2024 · 4 reports
    Assay
    human 5-HT1A receptor membranes; [3H]8-OH-DPAT competition binding
    Shown value from
    Puigseslloses et al. 2024, Table 1
    Range
    25–143 nM in 4 reports
    Error
    ± 7.6 SD

    This is the best-supported value. Other reports differ. 5 reports in all, 12–143 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 201658 nMTable 1
    Kozell et al. 2023143 nMTable 1
    Puigseslloses et al. 202425 nMTable 1
    Glatfelter et al. 202435 nMSupplement Figure S1
  • 2C-P110 nMRickli et al. 2015
    Assay
    cloned human receptor (HEK293)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 40 SD
  • PsilocinAgonistunresolvedrange incl. untraced164 nMGlatfelter et al. 2022 · 5 reports
    Assay
    Transfected-cell radioligand binding at human 5-HT1A (UNC PDSP)
    Shown value from
    Glatfelter et al. 2022, Table 1
    Range
    49–370 nM in 5 reports

    Reported values disagree and no value is established. 6 reports in all, 49–370 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 2016123 nMTable 1
    Glatfelter et al. 2022164 nMTable 1
    Jain et al. 2025370 nMTable S4
    Dodd et al. 2023123 nM, 49 nMTable 2
  • 2C-IAgonistunresolved180 nMRickli et al. 2015
    Assay
    cloned human receptor (HEK293)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 10 SD

    Reported values disagree and no value is established. 2 reports in all, 180–970 nM.

  • 2C-CAgonistunresolved190 nMRickli et al. 2015
    Assay
    cloned human receptor (HEK293)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 10 SD

    Reported values disagree and no value is established. 2 reports in all, 190–740 nM.

  • 2C-B240 nMRickli et al. 2015 · 2 reports
    Assay
    cloned human receptor (HEK293)
    Shown value from
    Rickli et al. 2015, Table 1
    Range
    240–241 nM in 2 reports
    Error
    ± 40 SD
    Sources and values behind the range, same assay family
    ReportValueWhere
    Ray 2010241 nMTable S2 (AllKiData)
    Rickli et al. 2015240 nMTable 1
  • DMTAgonistother reports differ356 nMKozell et al. 2023 · 5 reports
    Assay
    human 5-HT1A receptor in HEK cells; [3H]8-OH-DPAT competition binding
    Shown value from
    Kozell et al. 2023, Table 1
    Range
    75–450 nM in 5 reports
    Error
    ± 34 SEM, n = 17

    This is the best-supported value. Other reports differ. 5 reports in all, 75–450 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 201675 nMTable 1
    Kozell et al. 2023356 nMTable 1
    Janowsky et al. 2014450 nMTable 1
    Jain et al. 2025270 nMTable S4
    Eshleman et al. 2014400 nMTable 2
  • 2C-EAgonistunresolved360 nMRickli et al. 2015 · 2 reports
    Assay
    cloned human receptor (HEK293)
    Shown value from
    Rickli et al. 2015, Table 1
    Range
    307–360 nM in 2 reports
    Error
    ± 40 SD

    Reported values disagree and no value is established. 3 reports in all, 307–1190 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Ray 2010307 nMTable S2 (AllKiData)
    Rickli et al. 2015360 nMTable 1
  • 2C-DAgonistunresolved440 nMRickli et al. 2015
    Assay
    cloned human receptor (HEK293)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 10 SD

    Reported values disagree and no value is established. 2 reports in all, 440–1630 nM.

  • 4-HO-METAgonist950 nMKozell et al. 2023 · 3 reports
    Assay
    human 5-HT1A receptor in HEK cells; [3H]8-OH-DPAT competition binding
    Shown value from
    Kozell et al. 2023, Table 1
    Range
    135–950 nM in 3 reports
    Error
    ± 210 SEM, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 2016228 nMTable 1
    Kozell et al. 2023950 nMTable 1
    Glatfelter et al. 2023135 nMTable 2
  • ALD-521054 nMHalberstadt et al. 2020
    Assay
    cloned human 5-HT1A receptor; [3H]8-OH-DPAT competition
    Shown value from
    Halberstadt et al. 2020, Table 1
    Error
    ± 367 SEM, n = 5
  • 6-APB1500 nMRickli et al. 2015
    Assay
    cloned human 5-HT1A receptor binding
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 200 SD
  • DOI2219 nMRay 2010
    Assay
    PDSP receptorome (compiled; species not stated per entry, predominantly human clones)
    Shown value from
    Ray 2010, Table S2 (AllKiData)
  • DOB2550 nMRay 2010
    Assay
    PDSP receptorome (compiled; species not stated per entry, predominantly human clones)
    Shown value from
    Ray 2010, Table S2 (AllKiData)
  • 5-APB3300 nMRickli et al. 2015
    Assay
    cloned human 5-HT1A receptor binding
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 200 SD
  • DOM3660 nMEshleman et al. 2018 · 2 reports
    Assay
    recombinant human 5-HT1A receptor; [3H]8-OH-DPAT competition binding
    Shown value from
    Eshleman et al. 2018, Table 1
    Range
    3660–7238 nM in 2 reports
    Error
    ± 470 SEM, n = 4
    Sources and values behind the range, same assay family
    ReportValueWhere
    Luethi et al. 20267238 nMTable 1
    Eshleman et al. 20183660 nMTable 1
  • 4-FA4400 nMRickli et al. 2015
    Assay
    cloned human 5-HT1A receptor binding
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 800 SEM
  • Mescaline4600 nMRickli et al. 2015 · 2 reports
    Assay
    cloned human receptor (HEK293)
    Shown value from
    Rickli et al. 2015, Table 1
    Range
    1841–4600 nM in 2 reports
    Error
    ± 400 SD
    Sources and values behind the range, same assay family
    ReportValueWhere
    Ray 20101841 nMTable S2 (AllKiData)
    Rickli et al. 20154600 nMTable 1
  • MDA4900 nMRickli et al. 2015
    Assay
    cloned human 5-HT1A receptor binding
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 900 SD
  • 4-FMA5000 nMRickli et al. 2015
    Assay
    cloned human 5-HT1A receptor binding
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 1900 SEM
  • α-PVP5200 nMRickli et al. 2015
    Assay
    cloned human 5-HT1A receptor binding
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 100 SEM
  • Psilocybin5284 nMGlatfelter et al. 2022 · 2 reports
    Assay
    Transfected-cell radioligand binding at human 5-HT1A (UNC PDSP)
    Shown value from
    Glatfelter et al. 2022, Table 1
    Range
    5200–5284 nM in 2 reports
    Sources and values behind the range, same assay family
    ReportValueWhere
    Glatfelter et al. 20225284 nMTable 1
    Jain et al. 20255200 nMTable S4
  • Amphetamine6740 nMSimmler et al. 2013
    Assay
    Radioligand displacement binding in HEK293-cell membranes expressing human 5-HT1A
    Shown value from
    Simmler et al. 2013, Table 1
    Error
    ± 1380 SD
  • Methamphetamine8070 nMSimmler et al. 2013 · 3 reports
    Assay
    Radioligand displacement binding in HEK293-cell membranes expressing human 5-HT1A
    Shown value from
    Simmler et al. 2013, Table 1
    Range
    5900–9700 nM in 3 reports
    Error
    ± 750 SD
    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 20138070 nMTable 1
    Eshleman et al. 20149700 nMTable 2
    Eshleman et al. 20135900 nMTable 5

Mouse

5 measurements
  • 5-MeO-DMTAgonist3.3 nMGlatfelter et al. 2024
    Assay
    mouse brain membranes, [3H]8-OH-DPAT competition binding at 5-HT1A
    Shown value from
    Glatfelter et al. 2024, Supplement Figure S11
  • 5-MeO-MiPTAgonist27 nMGlatfelter et al. 2024
    Assay
    mouse brain membranes, [3H]8-OH-DPAT competition binding at 5-HT1A
    Shown value from
    Glatfelter et al. 2024, Supplement Figure S11
  • Cannabigerol (CBG)Antagonist52 nMCascio et al. 2010
    Assay
    MF1 mouse whole-brain membranes; antagonism of 8-OH-DPAT stimulated [35S]GTPγS binding, Schild analysis (five concentrations, slope 1.1, apparent KB)
    Shown value from
    Cascio et al. 2010, Figure 8 legend (Schild plot)
  • PsilocinAgonist118 nMGlatfelter et al. 2022
    Assay
    C57BL/6J mouse brain membranes; [3H]8-OH-DPAT displacement
    Shown value from
    Glatfelter et al. 2022, Table 3
  • Psilocybin197 nMGlatfelter et al. 2022
    Assay
    C57BL/6J mouse brain membranes; [3H]8-OH-DPAT displacement
    Shown value from
    Glatfelter et al. 2022, Table 3

Pig

2 measurements
  • LSDAgonist2.5 nMPaulke et al. 2013
    Assay
    porcine receptor membrane binding assay; pKi converted to Ki
    Shown value from
    Paulke et al. 2013, Table 2
  • LSA10 nMPaulke et al. 2013
    Assay
    porcine receptor membrane binding assay; pKi converted to Ki
    Shown value from
    Paulke et al. 2013, Table 2

Rat

4 measurements
  • LSDAgonist5.0 nMPfaff et al. 1994
    Assay
    rat frontal cortex homogenate; [3H]8-OH-DPAT displacement
    Shown value from
    Pfaff et al. 1994, Table 4 (same values in Table 5)
  • 5-MeO-DMTAgonistsource not traced20 nMGlennon 1987
    Assay
    5-HT1A site, [3H]-8-OH-DPAT (values compiled in a review, assays used rat cortex unless noted)
    Shown value from
    Glennon 1987, Table I
  • DMTAgonist130 nMDeliganis et al. 1991
    Assay
    Rat frontal cortex membranes, [3H]8-OH-DPAT competition without GTP
    Shown value from
    Deliganis et al. 1991, Results, Fig. 1A
    Error
    ± 6.0 SEM, n = 3
  • PsilocinAgonistsource not traced190 nMDodd et al. 2023
    Assay
    5-HT1A binding, compiled in a review (Table 2), original assay not restated
    Shown value from
    Dodd et al. 2023, Table 2

Unspecified

5 measurements
  • LSDAgonistsource not traced2.6 nMGlennon 1987
    Assay
    5-HT1A binding site (value for (+)-LSD quoted in the text of a review)
    Shown value from
    Glennon 1987, Text, section 5 (Ergolines)
  • 5-MeO-DMTAgonistrange incl. untraced3.7 nMChen et al. 2023 · 4 reports
    Assay
    5-HT1A receptor membranes (PerkinElmer 6110501400UA); [3H]8-OH-DPAT scintillation proximity competition binding
    Shown value from
    Chen et al. 2023, Table 2
    Range
    1.9–10 nM in 4 reports
    Error
    ± 0.95 SD, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Chen et al. 20233.7 nMTable 2
    Nelson 19911.9 nM, 7.8 nM, 10 nMTable 6, Table 6 (5-OMe-DMT)
  • BufoteninAgonistrange incl. untraced4.3 nMChen et al. 2023 · 2 reports
    Assay
    5-HT1A receptor membranes (PerkinElmer 6110501400UA); [3H]8-OH-DPAT scintillation proximity competition binding
    Shown value from
    Chen et al. 2023, Table 2
    Range
    4.3–25 nM in 2 reports
    Error
    ± 0.50 SD, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Chen et al. 20234.3 nMTable 2
    Glennon 198725 nMTable III
  • PsilocinAgonistrange incl. untraced84 nMChen et al. 2023 · 3 reports
    Assay
    5-HT1A receptor membranes (PerkinElmer 6110501400UA); [3H]8-OH-DPAT scintillation proximity competition binding
    Shown value from
    Chen et al. 2023, Table 2
    Range
    49–567 nM in 3 reports
    Error
    ± 26 SD, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Chen et al. 202384 nMTable 2
    Plazas et al. 202349 nMTable 5
    Dodd et al. 2023567 nMTable 2
  • DMTAgonistrange incl. untraced87 nMChen et al. 2023 · 3 reports
    Assay
    5-HT1A receptor membranes (PerkinElmer 6110501400UA); [3H]8-OH-DPAT scintillation proximity competition binding
    Shown value from
    Chen et al. 2023, Table 2
    Range
    87–245 nM in 3 reports
    Error
    ± 15 SD, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Chen et al. 202387 nMTable 2
    Keiser et al. 2009183 nMSupplementary Table 4
    Nelson 1991245 nMTable 6

Functional potency (EC₅₀)

8 substances, 11 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.

Human

8 measurements
  • LSDAgonistother reports differ1.3 nMEshleman et al. 2018 · 3 reports
    Assay
    recombinant human 5-HT1A receptor; [35S]GTPgammaS binding
    Shown value from
    Eshleman et al. 2018, Table 2
    Range
    1.3–6.4 nM in 3 reports
    Error
    ± 0.46 SEM, n = 3
    Emax
    93.2 ± 6.4%

    This is the best-supported value. Other reports differ. 5 reports in all, 0.26–6.4 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Eshleman et al. 20181.3 nMTable 2
    Eshleman et al. 20146.4 nMTable 2
    Eshleman et al. 20135.8 nMTable 6
  • 5-MeO-DMTAgonistother reports differ3.4 nMGlatfelter et al. 2024 · 2 reports
    Assay
    Transfected cells expressing human 5-HT1A; Galpha-oB dissociation BRET
    Shown value from
    Glatfelter et al. 2024, Figure 2A-B
    Range
    3.4–26 nM in 2 reports
    Emax
    115.0%

    This is the best-supported value. Other reports differ. 5 reports in all, 3.4–791 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Glatfelter et al. 20243.4 nMFigure 2A-B
    Warren et al. 202426 nMMain text, Structure-activity relationship of 5-MeO-tryptamines at 5-HT1A
  • DMTAgonistdepends on assayrange incl. untraced210 nMKozell et al. 2023 · 3 reports
    Assay
    human 5-HT1A receptor in HEK cells; [35S]GTPgammaS binding
    Shown value from
    Kozell et al. 2023, Table 1
    Range
    210–1490 nM in 3 reports
    Error
    ± 31 SEM, n = 18
    Emax
    97.1 ± 2.4%

    Values depend on the assay, species or conditions, and each is valid only for its own. 5 reports in all, 210–1585 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Kozell et al. 2023210 nMTable 1
    Cameron et al. 20181490 nMTable 2
    Eshleman et al. 20141490 nMTable 2
  • BufoteninAgonistdepends on assay366 nMBlough et al. 2014
    Assay
    human 5-HT1A receptor in CHO-G16 cells; calcium mobilization
    Shown value from
    Blough et al. 2014, Table 1
    Error
    ± 67 SEM, n = 3
    Emax
    95.0 ± 1.0%

    Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 9.3–366 nM.

  • 5-MeO-MiPTAgonistdepends on assay610 nMKozell et al. 2023
    Assay
    human 5-HT1A receptor in HEK cells; [35S]GTPgammaS binding
    Shown value from
    Kozell et al. 2023, Table 1
    Error
    ± 210 SEM, n = 8
    Emax
    109.1 ± 0.6%

    Values depend on the assay, species or conditions, and each is valid only for its own. 4 reports in all, 37–610 nM.

  • PsilocinAgonist1084 nMWarren et al. 2024
    Assay
    cells expressing human 5-HT1A; Gi1 activation BRET
    Shown value from
    Warren et al. 2024, Supplementary Table 1
    Emax
    88.7 ± 4.8%
  • 4-HO-METAgonist1390 nMKozell et al. 2023
    Assay
    human 5-HT1A receptor in HEK cells; [35S]GTPgammaS binding
    Shown value from
    Kozell et al. 2023, Table 1
    Error
    ± 490 SEM, n = 5
    Emax
    89.8 ± 5.8%
  • 2C-IAgonist4900 nMEshleman et al. 2014
    Assay
    HEK-h5-HT1A [35S]GTPγS functional assay
    Shown value from
    Eshleman et al. 2014, Table 2
    Error
    ± 2000 SEM
    Emax
    102.1%

Mouse

2 measurements
  • 5-MeO-DMTAgonist5.6 nMGlatfelter et al. 2024
    Assay
    Transfected cells expressing mouse 5-HT1A; Galpha-oB dissociation BRET
    Shown value from
    Glatfelter et al. 2024, Figure 2A-B
    Emax
    107.0%
  • 5-MeO-MiPTAgonist36 nMGlatfelter et al. 2024
    Assay
    Transfected cells expressing mouse 5-HT1A; Galpha-oB dissociation BRET
    Shown value from
    Glatfelter et al. 2024, Figure 2A-B
    Emax
    101.0%

Rat

1 measurement
  • DMTAgonistrange incl. untraced4000 nMDeliganis et al. 1991 · 2 reports
    Assay
    Rat hippocampal membranes, inhibition of forskolin-stimulated adenylate cyclase
    Shown value from
    Deliganis et al. 1991, Results, Fig. 2
    Emax
    30.0 ± 4.0%
    Sources and values behind the range, same assay family
    ReportValueWhere
    Cameron et al. 20184000 nMTable 2
    Deliganis et al. 19914000 nMResults, Fig. 2

Also reported to act here

Substances reported to act here, without a displayed value.

Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.